Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Optimal Level of Proteinuria Reduction for Renoprotection in Patients with IgA Nephropathy
저자 Ki Heon Nam1, Mi Jung Lee1, Jeong Hye Kie2, Beom Jin Lim3, Young Eun Kwon1, Yung Ly Kim1, Hyung Jung Oh1, Jung Tak Park1, Tae Ik Chang4, Ea Wha Kang4, Tae-Hyun Yoo1, Shin-Wook Kang1, Kyu Hun Choi1, Hyun Joo Jeong3, Seung Hyeok Han1
출판정보 2013; 2013(1):
키워드 IgA 신병증, 단백뇨, 예후/ IgA nephropathy, Proteinuria, Outcome
초록 Background: Proteinuria is a target for renoprotection in various glomerular diseases. However, optimal level of proteinuria reduction is unknown in patients with IgA nephropathy (IgAN). Therefore, we conducted a retrospective observational cohort study to investigate whether reducing proteinuria below the level that the current guideline suggests may confer a more renoprotective advantage. Methods: Among 644 participants who were pathologically diagnosed with IgAN in Yonsei University Severance Hospital and National Health Insurance Corporation Ilsan Hospital between 2000 and 2010, 500 subjects were eligible for the study. Time-averaged proteinuria (TA-P) was calculated as an average of the mean of every 6 month period of measurements of spot urine protein-to-creatinine ratio. The study endpoints were a doubling of the baseline serum creatinine concentration (D-sCr) and the onset of end-stage renal disease (ESRD). ESRD was defined as initiation of dialysis or receiving transplantation. Results: There were 221 (44.2%), 135 (27.0%), 96 (19.2%), and 48 (9.6%) patients with TA-P of <0.5, 0.5 to 0.99, 1.0 to 1.99, and ≥2.0 g/g, respectively. During a median follow-up duration of 65 (12-154) months, D-sCr was reached in 1 (0.5%), 3 (2.2%), 18 (18.8%), and 30 (62.5%) patients of each group (p<0.001). There was no difference in the development of D-sCr between patients with TA-P<0.5 g/g and those with TA-P of 0.5 to 0.99 g/g. ESRD did not occur in these two groups compared to 11 (11.5%) and 23 (47.9%) patients with TA-P of 1.0 to 1.99 and ≥2.0 g/g, respectively. In the multivariable Cox model after adjustment for age, estimated glomerular filtration rate, blood pressure, pathologic findings, and treatment, risk of reaching D-sCr did not differ between patients with TA-P of <0.5 g/g and those with 0.5 to 0.99 g/g [hazard ratio (HR), 1.95; 95% confidence interval (CI), 0.15 to 25.6; p=0.611], whereas it was markedly increased in patients with TA-P of 1.0 to 1.99 g/g (HR, 32.1; 95% CI, 3.07 to 336.5; p=0.004) and those with TA-P >2.0 g/g (HR, 153.0; 95% CI 13.8 to 1699.7; p<0.001). Conclusions: Our finding suggests that the optimal anti-proteinuric goal is <1.0 g/g in patients with IgAN. Further studies are required to clarify whether reduction of proteinuria of <0.5 g/g may confer a more renoprotective advantage.
원문(PDF) PDF 원문보기
위로가기